Log In
Print this Print this

Eryc (Erymax)

  Manage Alerts
Collapse Summary General Information
Company Mayne Pharma Group Ltd.
DescriptionDelayed release erythromycin developed using pellet technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentMarketed
Standard IndicationBacterial infection
Indication DetailsTreat bacterial infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today